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BACKGROUND:  Infection  in  the  neonatal period  is  an
extremely serious condition and diagnosis is difficult.
C-reactive protein (CRP) is widely used as a marker of
infection;  however,  its  usefulness  is  limited  in  the
early phase. The role of soluble intracellular adhesion
molecule-1  (sICAM-1),  an  adhesion  molecule,  has
been examined in recent studies as an early marker of
neonatal infection with controversial results.
Aim: Assessment of sICAM-1 concentrations and cor-
relation with CRP, which is the currently used marker
of  infection,  in  order  to  use  sICAM  as  an  early
diagnostic tool in neonates suspected for infection
Methods:  Blood  samples  and  blood  cultures  were
obtained from two groups of pre-term and full-term
neonates with clinical suspicion of infection prior to
the  initiation  of  antibiotics.  The  sICAM-1  and  CRP
values were compared with the corresponding non-
infected ones (n = 10 each).
Results: The sICAM-1 levels were found increased in
the group of both premature and term neonates with
infection compared with the corresponding healthy
ones (p < 0.0001). Prematurity combined with infec-
tion  resulted in  excessive  increase  of  the  levels  of
sICAM-1 in comparison with full-term infected new-
borns  (p  <  0.001).  CRP  values  were  normal  in  all
samples except one in both full-term and premature
infected  neonates  on  day  1  of  clinically  suspected
infection. Serial detection of CRP values on days 2 and
4 of infection revealed a pattern according to which
CRP values in premature neonates continued rising,
while in the group of full terms these values, after
rising on the second day, lowered on day 4.
Conclusions: Increased sICAM-1 levels can be detected
early in both full-term and premature neonates with
sepsis while CRP levels are within normal range at the
same time. Assessment of sICAM-1 concentrations may
be used as a diagnostic tool in neonates suspected for
infection, resulting in earlier initiation of antibiotic
therapy and therefore improving their outcome.
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Introduction
The immune system is not completely developed at
birth. Infection in the neonatal period is an extremely
serious condition and diagnosis is difficult due to the
lack of specific clinical symptoms and reliable early
laboratory indicators. Especially, premature neonates
have a reduced capacity to resist the infection, and
this impaired host defense results in increased mor-
bidity  and  mortality  in  the  neonatal period,  partic-
ularly among pre-term infants. Isolation of the causa-
tive organism from blood cultures takes up to 72h
and does not identify most infected infants. C-reactive
protein (CRP) is widely used as a marker of infection
and has been proved to be very effective  for early
detection of sepsis.1,2 However, the delayed rise after
the  onset  of  the  infection  (up  to  12h)  limits  its
usefulness in the early phase.3 Intercellular adhesion
molecule-1 (ICAM-1) participates in the adhesion of
leukocytes to the endothelium and may be crucial in
regulating leukocyte activation at a very early inflam-
matory response.4 Expression of adhesion molecules
is regulated by cytokine activation, and it has been
shown that several membrane-bound adhesion mole-
cules can be detected in the circulation in a soluble
form.5 Soluble ICAM-1 (sICAM-1) is normally present
in  the serum  of  healthy adults,6 and recent studies
examined the role of sICAM-1 in neonatal infections,
but  with  controversial  results.7–10 The  aim  of  this
study  is  to  compare  ICAM-1  and  CRP  values  in
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effect of prematurity on sICAM-1 expression, and to
correlate  with  the  presence  of  infection  and  CRP
values in  an  effort to  establish an early  marker  for
detection of infection in newborns.
Material and methods
All  newborn  infants  that  were  participating  in  the
study  had  been  delivered  at  the  State  Maternal
Hospital Alexandra, Athens during a 3-month period
(January 2000–March 2000).
The infants  were  recruited  into  the  study  at  the
time  of  evaluation  for  suspected  clinical  infection.
Inclusion  criteria  were  the  clinical  suspicion  of
infection  based  on  general  symptoms  (pallor  or
icterus),  neurological  symptoms  (lethargy,  apnea,
bradycardia,  irritability,  seizures),  respiratory  symp-
toms (tachypnea, retractions or respiratory distress),
cardiovascular symptoms (compromised microcircu-
lation, tachycardia or hypotension), abdominal symp-
toms (abdominal distension or vomitus) and fever or
temperature instability.
Antibiotic  treatment  was  started  when  indicated
(according  to  established  clinical  routine).  Blood
samples  for  sICAM-1  determination  and  blood  cul-
tures were obtained when the first clinical suspicion
for infection was raised and prior to the initiation of
antibiotics. The blood sample for sICAM-1 determina-
tion  from  the  premature  controls  was  matched  to
the  day  of  life  of  a  newly  diagnosed infected  one,
while that from the full-term controls was taken the
third day of life  on their release from  the hospital.
The serum was separated by centrifugation and was
stored at –20°C until assay. During the study period,
21 neonates fulfilled the inclusion criteria. For each
newborn with clinical suspicion of infection, a non-
infected  infant  control  has  been  included  in  the
study  according  to  the  gestational  age. The  infants
were classified into two groups.  Group  1  (control)
included  10  healthy  full-term  and  10  premature
neonates  (gestational  age,  25–35  weeks)  without
signs of infection. Group 2 included 21 neonates (10
term  neonates,  11  pre-term  neonates)  with  gener-
alized infection on the basis of the reported clinical
criteria. Ten  out  of  21  neonates  of  group  2  had
positive blood cultures.
For quantitation of sICAM-1 in serum samples, the
commercial  enzyme-linked  immunosorbent  assay,
ELISA-kit, was used (R&D Systems, Minneapolis, MN,
USA) following the manufacturer’s instructions. The
assay is  based  on a  sandwich ELISA principle  with
horseradish peroxidase-labeled secondary antibodies.
The characteristics of the study groups are presented
in Table 1. Written informed consent was obtained
from all parents (mother and/or father), and the study
has been approved by the Ethics Committee of the
Hospital.
Statistical analysis
All measurements were performed in duplicate. The
results of each group are expressed as the mean value
(ng/ml)  ±  standard error of  the  mean.  Differences
between groups were assessed by two-tail unpaired
t-test.  Correlations  were  determined  by  Pearson’s
coefficient (r). p < 0.05 was considered to indicate
statistical significance
Results
The sICAM-1 levels were found increased in the group
of term neonates with infection (710.7 ± 56.6ng/ml)
compared with the healthy full-term neonates (358.4
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Table 1. Clinical and laboratory characteristics of the study groups
Full term
neonates
Full-term
infected
neonates
Pre-term
neonates
Pre-term
infected
neonates
Gestational age (weeks) 40.2 ± 1.3 38.6 ± 3.1 31.9 ± 0.9 31 ± 1.1
Weight at birth (g) 3435 ± 73 2880 ± 131 1702 ± 115.5 1477 ± 230.0
Sex (female/male) 7/3 3/8 5/5 5/4
Peak value CRP (mg/dl) 2.2 ± 0.46 6.67 ± 2.48
CRP day 1 (mean ± SEM) 0.59 ± 0.09 1.11 ± 0.61
Apgar score 19 9.6 ± 0.2 7.2 ± 0.6 6.5 ± 0.55 5.1 ± 0.5
sICAM-1 (ng/ml)
[median (range)]
358.4 ± 28.9
[353.4
(233–538)]
710.7 ± 56.6
[653.2
(450–999)]
467.7 ± 44.5
[469.6
(257–755)]
1237.7 ± 73.8
[1225.2
(955–1769)]
p < 0.0001*,
p = 0.054**
p < 0.0001*,
p < 0.001‡
*Refers to the difference between the levels of sICAM-1 in the non-infected and infected groups of neonates.
**Refers to the difference between the levels of sICAM-1 in non-infected full-term and premature neonates.
‡Refers to the difference between the levels of sICAM-1 in infected full-term and premature neonates.± 28.8ng/ml, p < 0.0001). The group of premature
infants with infection also had higher levels of sICAM-
1 compared with those without infection (1237.7 ±
73.8 and 467.7 ± 44.9ng/ml, respectively; p < 0.0001)
and  with  healthy  full  terms  (p <  0.0001;  Fig.  1).
Prematurity  combined  with  infection  resulted  in
excessive increase of the levels of sICAM-1 in compar-
ison with full-term infected newborns (p < 0.0001). In
the  absence  of  infection,  the  difference  found
between  the  groups  of  premature  and  full-term
neonates was borderline statistically significant (p =
0.054) (Table 1).
Neonates  with  infection  and  positive  blood  cul-
ture  (n =  8)  had very  increased levels  of  sICAM-1
(1185 ± 120.3ng/ml) compared with those that had
only  clinical  signs  of  infection  (n =  13)  (824.16  ±
73.4ng/ml,  p =  0.01),  and all  but  one (20/21) had
normal CRP values.
CRP values were normal in all samples except one
on day 1 (when determination of sICAM-1 levels was
performed  as  well)  in  full-term  infected  neonates
(0.59 ± 0.09mg/dl). They increased on day 2 (2.2 ±
0.46mg/dl)  and  decreased,  but  without  reaching
normal levels, on day 4 (1.19 ± 0.32mg/dl; Fig. 2).
CRP values of premature neonates with infection on
day  1  were  found  normal  in  all  but  one,  but  they
increased the following days (day 2, 4.64 ± 1.93mg/
dl;  day 4,  6.67 ± 2.48mg/dl; Fig.  2).
In the subgroup  of premature newborns without
signs of infection, the gestational age (r = –0.62,  p
=  0.05)  and  birth  weight  (r =  –0.65,  p =  0.04)
negatively  correlated  with  the  levels  of  sICAM-1.
Birth weight, but not gestational age, was higher in
the neonates without infection either in  the group
of  full-term  or  that  of  premature  infants  (full-term,
2880  ±  131  and  3435  ±  73g;  premature,  1477  ±
230.0  and 1702  ± 115.5g;  with and without infec-
tion, respectively).
Discussion
The difficulties  in  diagnosing infection in  the new-
born are reflected in the great diversity of methods
described in  the  literature11 and in  the continuous
efforts to establish either a single or a combination
of markers that would provide useful information in
the clinical decisions about antibiotic treatment that
is  nowadays  given  to  all  suspected  severely  sick
babies.12
The  results  show  distinctly  different  patterns  of
expression of sICAM-1 between premature and full-
term  neonates  as  a  function  of  septic  process.
Concentrations of sICAM-1 are very high in neonates
with sepsis regardless of their gestational age. Even
though only 10 out of 21 neonates with infection had
positive blood culture, it is well known that a negative
blood  culture  does  not  exclude  sepsis.  On  the
contrary, while the CRP levels, which are the most
reliable  marker  in  use,  were  normal  at  the  day  of
sampling,  the  sICAM  values  were  elevated  in  all
infected neonates of the study, possibly indicative of a
higher sensitivity to infection of this marker. The high
number  of  negative  blood  cultures  in  cases  of
clinically  diagnosed  sepsis  in  combination  with
delayed  elevation  of  CRP  levels  in  neonates  with
infection further emphasizes the necessity for a more
reliable index for early diagnosis. sICAM measurement
is not simpler than CRP detection, but does, however,
require  a  minimum  amount  of  serum,  equipment
available to most hospital laboratories, gives  results
within the day, and could probably be incorporated in
routine infection laboratory tests.
sICAM-1 was  detected in  all  neonates, the  gesta-
tional age of whom ranged from 25 to 41 weeks. This
confirms  the  suggestion  of  Austgulen  et  al.7 that
constitutive shedding of at least this adhesion mole-
cule  is  an  established  component  of  the  immune
system as early as the 24th week of gestation.
Prematurity itself results in increased serum con-
centration of sICAM, as shown by the inverse strong
correlation  between  the  latter  and  the  gestational
age,  although  the  mean  value  of  sICAM  in  pre-
mature  infants  is  borderline  statistically  significant
compared  with  the  corresponding  level  in  full
terms.  An  additional  factor  contributing  to  the
elevation of sICAM could  be  birth weight, as indi-
cated by the strong inverse correlation between the
two parameters.
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FIG.  1.  sICAM-1  values  of  all  groups.  Horizontal  lines
represent the mean values of sICAM-1 of each group, open
symbols refer to premature infants, and filled symbols refer
to full-term infants.
FIG. 2. Serial measurements of the CRP values at the first 4
days  of  full-term  and  pre-term  neonates  with  infection.
Horizontal  lines  represent  the  CRP  mean  values  of  each
group on each day (1d, first day; 2d, second day; 4d, fourth
day), filled symbols refer to the group of full-term infants,
and open symbols refer to the group of premature infants.Furthermore the combination of prematurity with
infection seems to result  in  increased levels  of the
adhesion  molecule  sICAM-1. This  is  in  accordance
with Kuster and Degitz,8 who showed that sICAM-1
levels  increased  in  a  group  of  premature  neonates
with infection (24–36 weeks), and with Giannaki et
al.,13 who  showed  that  in  infection-free  full-term
neonates there is an increased release of both sICAM-
1  and  soluble  vascular  cell  adhesion  molecule-1,
although no infected neonates were included in this
latter study. On the contrary, Austgulen et al.7 did not
find any differences in ICAM-1, vascular cell adhesion
molecule-1  as  well  as  E-selectin  concentrations
between the premature group of infected and non-
infected  neonates.  The  discrepancy  among  these
studies may be due to differences in the classification
of the newborn infected infants and the postnatal age
of neonates at sampling.8,14
In  conclusion,  increased  sICAM-1  levels  can  be
detected in  both  full-term  and  premature  neonates
with sepsis as a response of the immune system to
inflammatory stimuli. As neonates with infection had
increased sICAM-1 levels and CRP levels within normal
range at the time of  the sampling,  measurement of
serum ICAM-1 could be a useful and early marker in
neonatal sepsis. Assessment of sICAM-1 concentrations
may be used as a diagnostic tool in neonates suspected
of infection, resulting in earlier initiation of antibiotic
therapy and therefore improving their outcome.
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